137 related articles for article (PubMed ID: 47335)
21. Radioimmunoassay of calcitonin in unextracted human serum: a sensitive method.
Emmertsen K; Marqversen J; Jensen FT; Hansen HH
Scand J Clin Lab Invest; 1982 Nov; 42(7):539-44. PubMed ID: 6186008
[TBL] [Abstract][Full Text] [Related]
22. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin- and katacalcin-like immunoreactivity in human seminal plasma.
Maier U; Woloszczuk W; Schuh H; Zechner O
Exp Clin Endocrinol; 1986 Nov; 88(1):89-94. PubMed ID: 3817006
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
25. [The setting up of human serum calcitonin radioimmunoassay and its clinical application].
Zhan Z; Meng X; Chen L; Zhou X; Liu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):236-40. PubMed ID: 10453498
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
27. On the presence of autoantibodies in the plasma of patients suffering from medullary carcinoma of the thyroid.
Calmettes C
Biomed Pharmacother; 1985; 39(4):195-8. PubMed ID: 3904856
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
[TBL] [Abstract][Full Text] [Related]
29. Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man.
Body JJ; Heath H
J Clin Endocrinol Metab; 1983 Nov; 57(5):897-903. PubMed ID: 6413526
[TBL] [Abstract][Full Text] [Related]
30. Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts.
Tashjian AH; Melvin EW
N Engl J Med; 1968 Aug; 279(6):279-83. PubMed ID: 5660301
[No Abstract] [Full Text] [Related]
31. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
Becker KL; Snider RH; Silva OL; Moore CF
Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of immunoreactive calcitonin in human milk.
Bucht E; Arver S; Sjöberg HE; Löw H
Acta Endocrinol (Copenh); 1983 Aug; 103(4):572-6. PubMed ID: 6613498
[TBL] [Abstract][Full Text] [Related]
33. Molecular weight forms of immunoreactive calcitonin in a patient with medullary carcinoma of the thyroid: dynamic studies with calcium, pentagastrin and somatostatin.
Bertagna XY; Bloomgarden ZT; Rabin D; Roberts LJ; Orth DN
Clin Endocrinol (Oxf); 1980 Aug; 13(2):115-23. PubMed ID: 6108170
[TBL] [Abstract][Full Text] [Related]
34. Gastrin-releasing peptide immunoreactivity in medullary thyroid carcinoma.
Matsubayashi S; Yanaihara C; Ohkubo M; Fukata S; Hayashi Y; Tamai H; Nakagawa T; Miyauchi A; Kuma K; Abe K
Cancer; 1984 Jun; 53(11):2472-7. PubMed ID: 6370416
[TBL] [Abstract][Full Text] [Related]
35. Release of calcitonin by cultures of medullary carcinoma of the thyroid.
Lichtenberger LM; Singer FR
Endocr Res Commun; 1975; 2(8):527-36. PubMed ID: 1222721
[TBL] [Abstract][Full Text] [Related]
36. A carbohydrate-containing form of immunoreactive calcitonin in transplantable rat medullary thyroid carcinomas.
O'Neil JA; Birnbaum RS; Jacobson A; Roos BA
Endocrinology; 1981 Mar; 108(3):1098-100. PubMed ID: 7460837
[TBL] [Abstract][Full Text] [Related]
37. Evidence for precursors of calcitonin/PDN 21 in human milk.
Bucht E; Sjöberg HE
Regul Pept; 1987 Oct; 19(1-2):65-71. PubMed ID: 3685455
[TBL] [Abstract][Full Text] [Related]
38. Purification, characterization and radioimmunoassay of thyrocalcitonin from rat thyroid glands.
Burford HJ; Ontjes DA; Cooper CW; Parlow AF; Hirsch PF
Endocrinology; 1975 Feb; 96(2):340-8. PubMed ID: 46198
[TBL] [Abstract][Full Text] [Related]
39. [Serum and urine calcitonin levels in patients with medullary thyroid carcinoma and with non-thyroidal cancer, and their immunological size-heterogeneity (author's transl)].
Morimoto S; Onishi T; Imanaka S; Kumahara Y; Okada Y; Takai S; Miyauchi A; Nishioka Y
Nihon Naibunpi Gakkai Zasshi; 1981 Aug; 57(8):1127-38. PubMed ID: 6274709
[No Abstract] [Full Text] [Related]
40. [Calcitonin concentration in the cerebrospinal fluid in patients with medullary thyroid carcinoma--passing of calcitonin through the blood-brain barrier].
Morimoto S; Onishi T; Nishimura J; Fukuo K; Lee S; Kono H; Imanaka S; Okada Y; Kumahara Y
Nihon Naika Gakkai Zasshi; 1982 Aug; 71(8):1125-8. PubMed ID: 7175316
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
